Cell Transformation, Neoplastic
"Cell Transformation, Neoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
Descriptor ID |
D002471
|
MeSH Number(s) |
C04.697.098.500 C23.550.727.098.500
|
Concept/Terms |
Cell Transformation, Neoplastic- Cell Transformation, Neoplastic
- Tumorigenic Transformation
- Transformation, Tumorigenic
- Transformations, Tumorigenic
- Tumorigenic Transformations
- Transformation, Neoplastic Cell
- Neoplastic Cell Transformation
- Cell Transformations, Neoplastic
- Neoplastic Cell Transformations
- Transformations, Neoplastic Cell
- Neoplastic Transformation, Cell
- Cell Neoplastic Transformation
- Cell Neoplastic Transformations
- Neoplastic Transformations, Cell
- Transformation, Cell Neoplastic
- Transformations, Cell Neoplastic
|
Below are MeSH descriptors whose meaning is more general than "Cell Transformation, Neoplastic".
Below are MeSH descriptors whose meaning is more specific than "Cell Transformation, Neoplastic".
This graph shows the total number of publications written about "Cell Transformation, Neoplastic" by people in this website by year, and whether "Cell Transformation, Neoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 3 | 0 | 3 | 1996 | 2 | 0 | 2 | 1997 | 2 | 0 | 2 | 1998 | 1 | 2 | 3 | 1999 | 1 | 2 | 3 | 2000 | 3 | 5 | 8 | 2001 | 2 | 0 | 2 | 2002 | 5 | 2 | 7 | 2003 | 3 | 2 | 5 | 2004 | 8 | 6 | 14 | 2005 | 4 | 4 | 8 | 2006 | 6 | 7 | 13 | 2007 | 5 | 4 | 9 | 2008 | 6 | 2 | 8 | 2009 | 7 | 3 | 10 | 2010 | 4 | 2 | 6 | 2011 | 3 | 10 | 13 | 2012 | 7 | 6 | 13 | 2013 | 7 | 5 | 12 | 2014 | 3 | 4 | 7 | 2015 | 5 | 5 | 10 | 2016 | 4 | 6 | 10 | 2017 | 4 | 4 | 8 | 2018 | 7 | 4 | 11 | 2019 | 3 | 2 | 5 | 2020 | 2 | 3 | 5 | 2021 | 0 | 4 | 4 | 2022 | 0 | 5 | 5 | 2023 | 1 | 1 | 2 | 2024 | 0 | 2 | 2 | 2025 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cell Transformation, Neoplastic" by people in Profiles.
-
Lim EL, DeGregori J. The Nature and Nurture of Carcinogenesis. Cancer Discov. 2025 Jun 03; 15(6):1090-1092.
-
Kent A, Yee Mon KJ, Hutchins Z, Putzel G, Zhigarev D, Grier A, Jia B, Kortlever RM, Barbet G, Evan GI, Blander JM. A stromal inflammasome Ras safeguard against Myc-driven lymphomagenesis. Nat Immunol. 2025 Jan; 26(1):53-67.
-
Faupel-Badger J, Kohaar I, Bahl M, Chan AT, Campbell JD, Ding L, De Marzo AM, Maitra A, Merrick DT, Hawk ET, Wistuba II, Ghobrial IM, Lippman SM, Lu KH, Lawler M, Kay NE, Tlsty TD, Rebbeck TR, Srivastava S. Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024 Nov; 24(11):792-809.
-
Garcia C, Miller-Awe MD, Witkowski MT. Concepts in B cell acute lymphoblastic leukemia pathogenesis. J Leukoc Biol. 2024 Jun 28; 116(1):18-32.
-
Brockman QR, Scherer A, McGivney GR, Gutierrez WR, Rytlewski J, Sheehan A, Warrier A, Laverty EA, Roughton G, Carnevale NC, Knepper-Adrian V, Dodd RD. Discrepancies in indel software resolution with somatic CRISPR/Cas9 tumorigenesis models. Sci Rep. 2023 09 08; 13(1):14798.
-
Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, Kuan FC, Marongiu F, Evans EJ, Moore DA, Rodrigues FS, Pich O, Bakker B, Cha H, Myers R, van Maldegem F, Boumelha J, Veeriah S, Rowan A, Naceur-Lombardelli C, Karasaki T, Sivakumar M, De S, Caswell DR, Nagano A, Black JRM, Mart?nez-Ruiz C, Ryu MH, Huff RD, Li S, Fav? MJ, Magness A, Su?rez-Bonnet A, Priestnall SL, L?chtenborg M, Lavelle K, Pethick J, Hardy S, McRonald FE, Lin MH, Troccoli CI, Ghosh M, Miller YE, Merrick DT, Keith RL, Al Bakir M, Bailey C, Hill MS, Saal LH, Chen Y, George AM, Abbosh C, Kanu N, Lee SH, McGranahan N, Berg CD, Sasieni P, Houlston R, Turnbull C, Lam S, Awadalla P, Gr?nroos E, Downward J, Jacks T, Carlsten C, Malanchi I, Hackshaw A, Litchfield K, DeGregori J, Jamal-Hanjani M, Swanton C. Lung adenocarcinoma promotion by air pollutants. Nature. 2023 04; 616(7955):159-167.
-
Schleicher WE, Pietras EM. Reduced PU.1 Expression Collaborates with Tet2 Loss to Trigger Myeloid Leukemogenesis. Blood Cancer Discov. 2022 09 06; 3(5):378-381.
-
Kumar R, Maurya AK, Parker KD, Kant R, Ibrahim H, Kabir MI, Kumar D, Weber AM, Agarwal R, Kuhn KA, Ryan EP, Raina K. Gender-based effect of absence of gut microbiota on the protective efficacy of Bifidobacterium longum-fermented rice bran diet against inflammation-associated colon tumorigenesis. Mol Carcinog. 2022 10; 61(10):941-957.
-
Goy E, Tomezak M, Facchin C, Martin N, Bouchaert E, Benoit J, de Schutter C, Nassour J, Saas L, Drullion C, Brodin PM, Vandeputte A, Molendi-Coste O, Pineau L, Goormachtigh G, Pluquet O, Pourtier A, Cleri F, Lartigau E, Penel N, Abbadie C. The out-of-field dose in radiation therapy induces delayed tumorigenesis by senescence evasion. Elife. 2022 03 18; 11.
-
Armstrong N, Storey CM, Noll SE, Margulis K, Soe MH, Xu H, Yeh B, Fishbein L, Kebebew E, Howitt BE, Zare RN, Sage J, Annes JP. SDHB knockout and succinate accumulation are insufficient for tumorigenesis but dual SDHB/NF1 loss yields SDHx-like pheochromocytomas. Cell Rep. 2022 03 01; 38(9):110453.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|